Cervical Cancer Screening and Gynecologic Visit Rates for Medicaid Enrollees with Mental and Substance Use Disorders
Links to Fileshttps://www.hilltopinstitute.org/wp-content/uploads/publications/Cervical-Cancer-Screening-and-Gynecologic-Visit-Rates-for-Medicaid-Enrollees-with-Mental-and-Substance-Use-Disorders-pdf.pdf
MetadataShow full item record
Type of Work17 pages
presentations (communicative events)
RightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Subjectscervical cancer screening rate
gynecologic visit rates
Medicaid enrollees with mental and substance use disorders
Hilltop Senior Research Analyst Michael Abrams, MPH, gave this presentation at the 138th American Public Health Association (APHA) Annual Meeting held November 6 through 10, 2010, in Denver, Colorado. Cervical Cancer Screening and Gynecologic Visit Rates for Medicaid Enrollees with Mental and Substance Use Disorders discusses the findings of a study that assessed PAP screening and gynecological visit rates experienced by women with non-affective psychosis versus other women with substance use disorder (SUD), bipolar or unipolar depression, or the absence of any of these illnesses (controls). The study found that women with psychosis or depression were more likely to receive PAP screening versus controls; and women with SUD with or without psychosis demonstrated reduced screening rates.